Brain Ultrafast Ultrasound Imaging
ConditionCHD - Congenital Heart Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-2
SponsorUniversity Hospital, Bordeaux
About this trial
Congenital heart defects affect 1 in 100 births in France, with rising prevalence due to better care. Despite improved survival, 40% of children post-surgery face neurological impairments, and some of them show brain lesions. Causes include heart defects, genetic syndromes, and surgeries. Some heart defects and support systems increase cerebral risks. Monitoring cerebral perfusion is difficult to assess but emerging ultrafast ultrasound offers real-time, non-invasive blood flow insights.
Eligibility criteria
Qualifiers
Every patient under 2 years old any sex or gender hospitalised in the congenital heart disease unit of the intensive care and anaesthesia for cardiovascular surgery, CHU de Bordeaux.
Open anterior fontanella
congenital heart disease
cardiac shock necessitating mechanical circulatory support.
Disqualifiers
Anechoic
Allergy to echocardiography gel.
Trial design
Treatments tested in this trial
- Ultrafast ultrasound (UFUS)
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov